Management Sciences for Health to Bolster Medicine Safety in Cameroon

Arlington, VA–April 1, 2025–Management Sciences for Health (MSH) is pleased to announce the launch of a new program in Cameroon to improve the country’s ability to monitor the safety and quality of new medicines.  The program will be carried out by Cameroon’s Ministry of Public Health through the end of 2025 with support from MSH and is made possible with funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Building upon the achievements of the pilot program implemented in 2023, this program will strengthen the country’s medicines safety monitoring system—known as pharmacovigilance—by improving staff’s skills and guidelines to collect data and improve governance and coordination practices among key stakeholders. 

“A strong pharmacovigilance system ensures that every patient in Cameroon—whether receiving treatment for HIV, tuberculosis, malaria or other diseases—can trust that their medicines are safe and effective,” said Vice-President for Global Health Systems Innovation Dan Schwarz at MSH. “By continuing this critical work, we are not only improving medicine safety monitoring but also building the infrastructure, skills, and systems needed to protect patients as new treatments and vaccines become available.”

MSH is a recognized leader in pharmaceutical systems strengthening, with decades of experience helping low- and middle-income countries take a systems approach to ensuring sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and pharmaceutical services.

For more information, visit www.msh.org